Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

College Station, Texas 77845


This is an open label, multi-center, multi-application pharmacokinetic study in pediatric subjects with tinea corporis.


Inclusion Criteria: - Male or females 2 to 11 years, 11 months of any race. Females of child producing age (started menarche) must have a negative urine pregnancy test. - Presence of tinea corporis characterized by clinical evidence of a tinea infection at multiple sites covering a total of at least 1% body surface area. - KOH positive and culture positive baseline skin scrapings obtained from the site most severely affected of the overall severity. - Subjects must be in good health and free from clinically significant disease that might interfere with the study evaluations. Exclusion Criteria: - Tinea infection of the scalp, face, groin, and/or feet. - A life-threatening condition (ex. autoimmune deficiency syndrome, cancer) within the last 6 months - Subject with abnormal findings-physically or laboratory- that considered by the investigator to be clinically important and indicative of conditions that might complicate interpretation of study results. - Subjects with a known hypersensitivity or other contradictions to study medications or their components.



Primary Contact:

Study Director
Alan B. Fleischer, MD
Merz Pharmaceuticals, LLC

Backup Contact:


Location Contact:

College Station, Texas 77845
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.